Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Am J Transplant. 2014 Oct 10;14(11):2623–2632. doi: 10.1111/ajt.12926

Table 1.

Clinical and laboratory characteristics at diagnosis.

Pt Demographic data Order of Renal Tx History of nephrolithiasis* Suspected cause of CKD Delay of diagnosis after Tx (weeks) Renal manifestations
Age Gender Origin HTN Pu/Hu/Lu sCr at diagnosis (μmol/L) Graft dysfunction
1 28 F France 1st + (11) CTIN/nephrolithiasis, solitary kidney 5 + − / − / NA 150 AGD
2 41 M France 1st Undetermined 144 + + / + / − 248 A/CGD
3 48 M Italy 2nd + (30) Undetermined 72 − / + / − 283 A/CGD
4 48 M France 2nd Oxalate nephropathy 1.5 + + / + / + 676/Hemodialysis DGF
5 51 M Canada 1st + (43) Undetermined 312 − / − / NA 366 A/CGD
6 49 F Italy 1st Undetermined 156 − / + / − 430 A/CGD
7 58 F France 1st + (13) CTIN/nephrolithiasis 1.5 + − / + / − 109 -
8 64 M France 1st Undetermined 4 + + / − / − 600/Hemodialysis DGF
9 67 F Italy 1st + (52) Hypertensive nephrosclerosis 3 + − / − / NA 442/Hemodialysis A/CGD

Pt, patient; F, female; M, male; Tx, transplant; CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephropathy; HTN, hypertension; Pu/Hu/Lu, proteinuria, hematuria, leukocyturia; sCr, serum creatinine; NA, not available; AGD, acute graft dysfunction; A/CGD, acute-on-chronic graft dysfunction; DGF, delayed graft function.

*

Delay between the first kidney stone episode and diagnosis (years). Conversion factor from μmol/L to mg/dL = 0.0113.